Biotech Company B

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instance_of gptkb:biotechnology
gptkbp:annual_report gptkb:2023
gptkbp:approves FDA Approved
gptkbp:awards Best Startup 2021
2023 Innovator Award
gptkbp:benefits gptkb:Health_Insurance
gptkbp:ceo gptkb:Jane_Doe
gptkbp:clinical_trial gptkb:300
gptkb:California
Phase 2
Phase 3
gptkbp:collaboration Pharma Corp.
gptkbp:collaborations gptkb:Health_Insurance
gptkbp:community_engagement Local Schools Program
gptkbp:community_outreach Health Fairs
gptkbp:competitors Bio Tech Innovations
gptkbp:customer_base 5000 Clients
gptkbp:employees gptkb:200
gptkbp:environmental_impact gptkb:Low
gptkbp:focus_area Genetic Engineering
gptkbp:founded_in gptkb:2010
gptkbp:founder gptkb:John_Smith
gptkbp:funding 20 million USD
gptkbp:grants gptkb:National_Institutes_of_Health
gptkbp:headcount 150
gptkbp:headquarters gptkb:San_Francisco,_California
https://www.w3.org/2000/01/rdf-schema#label Biotech Company B
gptkbp:invention gptkb:15
gptkbp:investment gptkb:Series_B
10 million USD
Venture Capital Group
gptkbp:location gptkb:Silicon_Valley
gptkbp:market gptkb:North_America
gptkbp:market_cap 200 million USD
gptkbp:market_launch gptkb:2021
gptkb:2022
gptkbp:member gptkb:Alice_Johnson
gptkbp:partnership gptkb:Tech_Solutions_Inc.
gptkb:University_of_California
gptkbp:patent_filing gptkb:2023
gptkbp:product gptkb:Gene_Therapy
Ongoing
gptkbp:product_type Therapeutics
gptkbp:publication gptkb:Journal_of_Biotechnology
gptkbp:research_areas gptkb:CRISPR_Technology
gptkbp:revenue 50 million USD
gptkbp:social_media @ Biotech Company B
gptkbp:strategic_goals 2025 Vision
gptkbp:student_enrollment 90%
gptkbp:subsidiary Biotech Company B Europe
gptkbp:supply_chain Local Suppliers
gptkbp:sustainability_initiatives Green Lab Practices
gptkbp:technology Biomanufacturing
gptkbp:training Annual Workshops
gptkbp:website www.biotechcompanyb.com
gptkbp:bfsParent gptkb:Astoria_Capital
gptkbp:bfsLayer 7